The circulating metatranscriptome of 411 patients with acute myeloid leukemia is characterized and it is found that the circulating metatranscriptome in AML differs substantially from that of healthy controls, and high metatranscriptome loads are associated with antibacterial host response.
Abstract
The human microbiome comprises the collection of microbiota residing on or within human tissues. It is now well-established that microbial composition impacts an individual’s health. In the cancer realm, the vast majority of microbiome studies have been focused either on the gut, or at the site of solid tumors. Few studies have assessed microbial content at the site of hematological malignancies – blood and bone marrow. Here we characterize the circulating metatranscriptome (i.e. the bacterial and viral RNA in circulation) of 411 patients with acute myeloid leukemia (AML). We find that the circulating metatranscriptome in AML differs substantially from that of healthy controls, and high metatranscriptome loads are associated with antibacterial host response. We observe that specific bacterial genera are associated with response to anti-cancer therapy and disease history, and are tied to host gene expression signatures of heme metabolism. Overall, our study represents an inferred landscape of circulating microbial RNA in AML and suggests potential for its use as a biomarker.
BACKGROUND
Intratumoral bacteria are increasingly recognized as active contributors to neutrophil-driven inflammation and disease progression in solid tumors. Yet, in clear cell renal cell carcinoma (ccRCC), where myeloid inflammation is a key feature of aggressive disease, live bacterial presence, their intratumoral d...
Alice C. Martin, A. Cattin, Parise K. Lockwood et al.· i Medicina· 0 citations
Microbial constituents in the gastrointestinal tract, the urine and prostate tissue are being linked with clinical differences in prostate cancer, and a recent meta-analysis has linked periodontal disease to this cancer. Several hypotheses exist regarding how specific bacteria can contribute towards the development of...
A. Gihawi, A. Bampalis, Шиамсундар Субраманиан et al.· npj Biofilms and Microbiomes· 0 citations
ABSTRACT Chronic lymphocytic leukemia (CLL) is highly heterogeneous both clinically and biologically. Although genetic factors have been identified, several lines of evidence suggest a role for environmental factors in disease onset and progression. Diet is a recognized risk factor for various diseases, including cance...
M. Frenquelli, D. Farinello, Sofia Sisti et al.· Gut microbes reports· 0 citations
Human tumor-associated microbes – the tumor microbiome – have demonstrated an increasingly important role in human health due to their relevance to cancer progression and treatment response. While the metabolism at the host-microbiota interface, such as in the human gut, has been extensively investigated in recent year...
Conor Pulliam, Ming-Ming Xu, Katherine S. Holandez-Lopez et al.· Nature Communications· 0 citations
To explore the role of gut microbiota and bile acid metabolism in Acute myeloid leukemia (AML), we analyzed samples from 29 patients via 16S rDNA sequencing and LC-QTOF-MS, and performed functional studies on Enterococcus faecalis and hyodeoxycholic acid (HDCA). Results revealed a dynamic shift in gut microbiota divers...
Jian-Da Hu, Wan-Ying Liu, Jia-Jie Yang et al.· Clinical science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.